Literature DB >> 35802841

Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.

Christopher T Su1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35802841      PMCID： PMC9509202          DOI： 10.1200/OP.22.00357

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN： 2688-1527


× No keyword cloud information.
  31 in total

1.  Impact of trained oncology financial navigators on patient out-of-pocket spending.

Authors:  Todd Yezefski; Jordan Steelquist; Kate Watabayashi; Dan Sherman; Veena Shankaran
Journal:  Am J Manag Care       Date:  2018-03       Impact factor: 2.229

2.  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.

Authors:  Jonas A de Souza; Bonnie J Yap; Fay J Hlubocky; Kristen Wroblewski; Mark J Ratain; David Cella; Christopher K Daugherty
Journal:  Cancer       Date:  2014-06-20       Impact factor: 6.860

3.  Drug Recovery and Copay Assistance Program in a Community Cancer Center: Charity and Challenges.

Authors:  Robert D Siegel; Richard G Slough; Howland E Crosswell; Theresa M Standifer; Michael E Borron; Dionne L Pringle; Karen K Hancock; Lara H Widener; Erin B Hill; Terra F Spann; Kristina M Stoeppler-Biege
Journal:  J Oncol Pract       Date:  2019-06-04       Impact factor: 3.840

4.  Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.

Authors:  Marques S N Ng; Kai Chow Choi; Dorothy N S Chan; Cho Lee Wong; Weijie Xing; Pui Shan Ho; Cecilia Au; Mandy Chan; Man Tong; Wai Man Ling; Maggie Chan; Suzanne S S Mak; Raymond J Chan; Winnie K W So
Journal:  Support Care Cancer       Date:  2021-04-02       Impact factor: 3.603

5.  Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.

Authors:  Thomas G Knight; Melissa Aguiar; Myra Robinson; Allison Morse; Tommy Chen; Rupali Bose; Jing Ai; Brittany K Ragon; Aleksander L Chojecki; Nilay A Shah; Srinivasa R Sanikommu; James Symanowski; Edward A Copelan; Michael R Grunwald
Journal:  JCO Oncol Pract       Date:  2022-06-16

6.  Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients.

Authors:  Gelareh Sadigh; Kathleen Gallagher; Jennifer Obenchain; Al Benson; Edith Mitchell; Soma Sengupta; Ruth C Carlos
Journal:  J Am Coll Radiol       Date:  2019-10       Impact factor: 5.532

7.  Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes.

Authors:  Grace L Smith; Maria A Lopez-Olivo; Pragati G Advani; Matthew S Ning; Yimin Geng; Sharon H Giordano; Robert J Volk
Journal:  J Natl Compr Canc Netw       Date:  2019-10-01       Impact factor: 11.908

8.  Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.

Authors:  Ariela Noy; Sven de Vos; Morton Coleman; Peter Martin; Christopher R Flowers; Catherine Thieblemont; Franck Morschhauser; Graham P Collins; Shuo Ma; Shachar Peles; Stephen D Smith; Jacqueline C Barrientos; Elizabeth Chong; Shiquan Wu; Leo W-K Cheung; Kevin Kwei; Bernhard Hauns; Israel Arango-Hisijara; Robert Chen
Journal:  Blood Adv       Date:  2020-11-24

9.  Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020.

Authors:  Christopher T Su; Christine M Veenstra; Minal R Patel
Journal:  Cancers (Basel)       Date:  2022-03-22       Impact factor: 6.639

Review 10.  Evidence of the Feasibility and Preliminary Efficacy of Oncology Financial Navigation: A Scoping Review.

Authors:  Meredith J Doherty; Bridgette Thom; Francesca Gany
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-02       Impact factor: 4.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.